Today › Pharmaceuticals › Glenmark Pharmaceuticals

Pharmaceuticals Historical case study · data as of 10 Jul 2026 · published 15 Oct 2026 (97 days later)

Glenmark Pharmaceuticals — 100-point case study

How Glenmark Pharmaceuticals looked on 50 technical and 50 fundamental measures on 10 Jul 2026 — and what happened over the next three months. Education only; not a current view.

Codes	NSE: GLENMARK · BSE: 532296
Close on 10 Jul 2026	₹2,282.90
Market cap then	₹64,486 crore
Valuation	P/E 47.4× · P/B 6.13×
Momentum	RSI (14) 58 · 1-year return +19.9%
Next 3 months	-1.6% vs Nifty 50 -6.5% (to 14 Oct 2026)

Scorecard

Technical — 50 points

26 bullish · 21 neutral · 1 caution · 1 bearish — the picture leaned positive.

Fundamental — 50 points

13 bullish · 30 neutral · 5 caution · 1 bearish — the picture leaned positive.

Price chart

Close (to snapshot) Close (after) 50-day avg 200-day avg Support Resistance

Technical analysis — 50 points

Calculated by code from daily prices up to 10 Jul 2026. Standard formulas (RSI, MACD, ADX use Wilder smoothing).

How to read the tags. Each of the 50 points gets one tag. Bullish the reading was favourable. Bearish the reading was unfavourable. Neutral the reading was in a normal range, or gave no clear message. Caution a warning sign or an unusual reading that deserves a closer look. Point 50 counts the other 49 tags. The chart is called positive when bullish tags beat bearish ones by 5 or more, negative when bearish tags beat bullish ones by 5 or more, and mixed otherwise. Under each point you will see what reading earns which tag. Tags describe the data on the snapshot date. They are not signals to buy or sell. Full guide to all 100 points →

A. Trend

#	Point	Reading	Tag	Commentary
1	Short-term trend (20 days)	slope +0.27%/day	Bullish	Over the last 20 sessions the regression line of closing prices was rising about 0.27% a day — a short-term uptrend. Bullish slope above +0.10% a day (short-term uptrend) · Bearish slope below –0.10% a day (short-term downtrend) · Neutral between the two: a flat, sideways phase.
2	Medium-term trend (~5 months)	3M return +5.0%	Bullish	The 100-session trend line was up (+0.08%/day) and the stock was +5.0% over three months, so the medium-term picture was bullish. Bullish slope above +0.05% a day · Bearish slope below –0.05% a day · Neutral in between.
3	Long-term trend (1 year)	1Y return +19.9%	Bullish	Compared with a year earlier the price was +19.9%. A strong positive year. Bullish up more than 10% in a year · Bearish down more than 10% in a year · Neutral between –10% and +10%.
4	Weekly chart trend	10W 2,242.82 / 30W 2,148.51	Bullish	On the weekly chart the stock showed a weekly close above a rising 10-week and 30-week average stack. Bullish weekly close above the 10-week average, which is above the 30-week · Bearish weekly close below the 10-week average, which is below the 30-week · Neutral when they are tangled.
5	Swing structure (highs/lows)	last highs 2,252.50→2,234.90; lows 2,101.00→2,142.80	Neutral	The two most recent swing points showed a lower high but a higher low — mixed structure. Bullish higher highs and higher lows (uptrend structure) · Bearish lower highs and lower lows (downtrend structure) · Neutral when one is higher and the other lower.
6	ADX (14) — trend strength	14.2	Neutral	ADX at 14.2 signals a weak or absent trend (below 20) — range-bound conditions. ADX measures strength only, not direction. Bullish ADX 20 or more with +DI above –DI (a real trend, pointing up) · Bearish ADX 20 or more with –DI above +DI (a real trend, pointing down) · Neutral below 20: no clear trend. 20–30 is a moderate trend, above 30 a strong one.
7	+DI vs –DI	+DI 17.4 / –DI 14.8	Bullish	+DI was above –DI: upward price pressure outweighed downward pressure. Bullish +DI above –DI · Bearish –DI above +DI · No neutral zone for this point.

B. Moving averages

#	Point	Reading	Tag	Commentary
8	Price vs 20-day SMA	2,198.35 (+3.8%)	Bullish	Close of 2,282.90 was 3.8% above the 20-day SMA — the short-term trend filter was positive. Bullish close above the average · Bearish close below the average · No neutral zone.
9	Price vs 50-day SMA	2,259.39 (+1.0%)	Bullish	Close of 2,282.90 was 1.0% above the 50-day SMA — the medium-term trend filter was positive. Bullish close above the average · Bearish close below the average · No neutral zone.
10	Price vs 200-day SMA	2,077.17 (+9.9%)	Bullish	Close of 2,282.90 was 9.9% above the 200-day SMA — the long-term trend filter was positive. Bullish close above the average · Bearish close below the average · No neutral zone.
11	9 / 21 EMA crossover	9E 2,238.74 / 21E 2,220.96	Bullish	The 9-day EMA was above the 21-day EMA; the last crossover happened on 06 Jul 2026. Bullish 9-day above 21-day · Bearish 9-day below 21-day · No neutral zone.
12	Golden / death cross (50 vs 200)	no cross in data window	Bullish	The 50-day average was 8.8% above the 200-day. No 50/200 crossover occurred in the data window. Bullish 50-day above 200-day (after a “golden cross”) · Bearish 50-day below 200-day (after a “death cross”) · No neutral zone.
13	50-day SMA slope	-0.2% in 20 sessions	Neutral	The 50-day average fell 0.2% over the past month — flattening. Bullish rose more than 0.5% · Bearish fell more than 0.5% · Neutral in between: flattening.
14	MA ribbon alignment	2,198 / 2,259 / 2,204 / 2,077	Neutral	The 20/50/100/200-day averages were tangled — no clean order, typical of a transition or range. Bullish neatly stacked 20 > 50 > 100 > 200 · Bearish neatly stacked 20 < 50 < 100 < 200 · Neutral when tangled (a transition or range).
15	Monthly anchored VWAP	2,237.29 (+2.0%)	Bullish	Anchored to the start of July, the volume-weighted average price was 2,237.29; the close was above it — buyers that month were on average in profit. Bullish close above VWAP (that month’s buyers on average in profit) · Bearish close below VWAP · No neutral zone.

C. Momentum

#	Point	Reading	Tag	Commentary
16	RSI (14)	58.2	Bullish	RSI at 58.2 showed positive momentum without being overbought. Bullish RSI 55–70 (positive momentum, not stretched) · Bearish RSI 30–45 (soft momentum) · Neutral 45–55. Caution at 70 or above (overbought) or 30 or below (oversold).
17	RSI divergence (last 40 days)	bullish divergence	Bullish	Comparing the last 20 sessions with the 20 before: bullish divergence: price made a lower low but RSI made a higher low — selling momentum was fading. Bullish bullish divergence: price made a lower low but RSI a higher low · Caution for a bearish divergence (price higher high, RSI lower high). Neutral when RSI moved in line with price.
18	MACD line vs signal	MACD 9.01 / signal -5.69	Bullish	MACD was above its signal line — momentum turning or staying positive. Bullish MACD above signal · Bearish MACD below signal · No neutral zone.
19	MACD histogram (5-day change)	12.73 → 14.70	Bullish	The histogram rose over the last five sessions, meaning momentum was improving. Bullish histogram rising (momentum improving) · Bearish histogram falling (momentum weakening) · No neutral zone.
20	MACD vs zero line	9.01	Bullish	MACD above zero means the 12-day EMA was above the 26-day EMA — a positive momentum regime. Bullish MACD above zero · Bearish MACD below zero · No neutral zone.
21	Stochastic (14,3,3)	%K 75.0 / %D 76.3	Bearish	Slow stochastic at 75.0 was mid-range with %K below %D. Bullish between 20 and 80 with %K above %D · Bearish between 20 and 80 with %K below %D · Caution above 80 (overbought) or below 20 (oversold).
22	Williams %R (14)	-13.1	Caution	%R of -13.1 put the close near the top of its 14-day range. How to read: Caution above –20 (near the top) or below –80 (near the bottom). Neutral in the middle. This point is never tagged Bullish or Bearish.
23	CCI (20)	160	Bullish	CCI at 160 signalled an unusually strong upward deviation (>+100). Bullish above +100 (unusually strong upward move) · Bearish below –100 (unusually strong downward move) · Neutral within ±100.
24	Rate of change (10-day)	+6.0%	Bullish	Price changed +6.0% over ten sessions. Bullish up more than 2% · Bearish down more than 2% · Neutral between –2% and +2%.

D. Volatility

#	Point	Reading	Tag	Commentary
25	Bollinger Band position (%B)	%B 0.98 (bands 2,110.53–2,286.17)	Neutral	%B of 0.98 — inside the bands, upper half. How to read: Caution above 1 or below 0 (outside the bands — an overextended move). Neutral inside the bands.
26	Bollinger width / squeeze	width 8.0% (22nd pct of 6M)	Neutral	Band width was at the 22nd percentile of the last six months, a normal level. How to read: Caution when the width is in the lowest 15% of six months (a “squeeze” that often comes before a bigger move, direction unknown). Neutral otherwise.
27	ATR (14)	₹62.54 (2.7% of price)	Neutral	A typical day's range was about ₹62.54, or 2.7% of the price — useful for judging how much 'normal noise' to expect. How to read: Information only. A higher % means bigger normal daily swings.
28	Historical volatility (30-day)	27.0% vs 1Y 30.3%	Neutral	Annualised 30-day volatility was 27.0%, close to the one-year level of 30.3%. How to read: Caution when 30-day volatility is more than 1.25× the one-year level. Neutral otherwise.
29	Keltner Channel (20, 2×ATR)	2,098.68–2,343.70	Neutral	The close was inside the channel, so no volatility breakout. Bullish close above the upper channel (strong upward push) · Bearish close below the lower channel · Neutral inside the channel.
30	Beta vs Nifty 50 (1Y daily)	0.77	Neutral	A beta of 0.77 means the stock tended to move less than the Nifty 50 day to day. How to read: Information only. Above 1.1 moves more than the market, below 0.9 less, around 1 in line.

E. Volume & money flow

#	Point	Reading	Tag	Commentary
31	Volume vs 20-day average	last day 1.05× / 5-day 0.96×	Neutral	The final session traded 1.05× its 20-day average volume and the last five sessions averaged 0.96× — normal participation. How to read: Information only. Above 1.2× is heavier than usual participation, below 0.8× lighter.
32	Up-day vs down-day volume (20d)	ratio 1.23	Bullish	Average volume on up days was 1.23× that on down days — accumulation-leaning. Bullish ratio above 1.15 (accumulation-leaning) · Bearish ratio below 0.85 (distribution-leaning) · Neutral between 0.85 and 1.15.
33	On-Balance Volume (20d)	OBV rising	Bullish	OBV rose over the month while price rose — volume confirmed the price move. Bullish OBV rising · Bearish OBV falling · No neutral zone.
34	Accumulation/Distribution line	rising (20d)	Bullish	The A/D line rose, meaning closes tended to be in the upper part of daily ranges on meaningful volume. Bullish A/D line rising · Bearish A/D line falling · No neutral zone.
35	Chaikin Money Flow (20)	0.07	Bullish	CMF at +0.07 indicated net inflows. Bullish above +0.05 (net inflows) · Bearish below –0.05 (net outflows) · Neutral between –0.05 and +0.05.
36	Money Flow Index (14)	74.8	Bullish	MFI, a volume-weighted RSI, was 74.8. Bullish MFI 55–80 · Bearish MFI 20–45 · Neutral 45–55. Caution above 80 (overbought) or below 20 (oversold).
37	Liquidity (avg daily turnover)	₹126 cr/day	Neutral	About ₹126 crore changed hands per day on average over 20 sessions — liquid. How to read: Information only. Above ₹500 crore a day is highly liquid, above ₹50 crore liquid, below that moderately liquid.

F. Price levels

#	Point	Reading	Tag	Commentary
38	Support levels (S1/S2/S3)	2,225.03 / 2,123.07 / 2,008.85	Neutral	Nearest support (prior swing lows) sat at 2,225.03, 2.6% below the close, then 2,123.07, 2,008.85. How to read: Information only. Levels to watch, not good or bad.
39	Resistance levels (R1/R2/R3)	2,413.85 / 2,474.00	Neutral	Nearest resistance (prior swing highs) sat at 2,413.85, 5.7% above the close, then 2,474.00. How to read: Information only.
40	Monthly pivot points (for next month)	P 2,243.27 \| R1 2,343.73 \| S1 2,182.43	Neutral	Classic pivots from July's high/low/close gave a pivot of 2,243.27; the close was above it. How to read: Information only.
41	Fibonacci retracement (6M swing)	23.6% 2,325 \| 38.2% 2,233 \| 50.0% 2,158 \| 61.8% 2,083	Neutral	Measuring the 6-month rise from 1,842.00 to 2,474.00, the close was nearest the 23.6% retracement at 2,324.85. How to read: Information only.
42	52-week high / low	H 2,474.00 / L 1,775.00	Neutral	The close was 7.7% below the 52-week high and 28.6% above the 52-week low. Bullish within 5% of the 52-week high · Bearish within 5% of the 52-week low · Neutral in between.
43	Unfilled price gaps (6M)	none	Neutral	No unfilled price gaps in the last six months. How to read: Information only.

G. Patterns

#	Point	Reading	Tag	Commentary
44	Price structure / chart pattern	rising channel	Bullish	Rule-based pattern scan: rising channel — successive higher highs and lows. (Classical patterns like head-and-shoulders are judgement calls; we report only what the rules detect.) Bullish rising channel (both trends up) · Bearish falling channel (both trends down) · Neutral for tight consolidation, a bounce in a downtrend, a pullback in an uptrend, or a sideways range.
45	Breakout / breakdown (20-day)	range 2,101.00–2,293.90	Neutral	The close was inside the prior 20-day range of 2,101.00–2,293.90. Bullish close above the 20-day high (breakout) · Bearish close below the 20-day low (breakdown) · Neutral inside the range.
46	Latest candlestick	Doji	Neutral	On 10 Jul the candle opened 2,283.90, ranged 2,247.00–2,304.10 and closed 2,282.90: Doji — indecision. Single candles are weak signals on their own. Bullish hammer, bullish engulfing or bullish marubozu · Bearish shooting star, bearish engulfing or bearish marubozu · Neutral for a doji, inside bar or ordinary candle. Single candles are weak signals.
47	Ichimoku Cloud	cloud 2,220.25–2,294.12; Tenkan 2,223.45 / Kijun 2,202.55	Neutral	Price was inside the cloud and the Tenkan line was above the Kijun line — an undecided Ichimoku setup. Bullish close above the cloud · Bearish close below the cloud · Neutral inside the cloud.

H. Relative strength & summary

#	Point	Reading	Tag	Commentary
48	Relative strength vs Nifty 50	1M +2.2% / 3M +4.2%	Bullish	The stock outperformed the Nifty 50 by 4.2 points over three months and outperformed by 2.2 points over one month. Bullish ahead of the Nifty 50 by more than 2 points · Bearish behind by more than 2 points · Neutral within ±2 points.
49	Relative strength vs Nifty 50 (6M)	6M +20.1%	Bullish	No sector index in today's data set, so we show the 6-month comparison instead: 20.1 points ahead of the Nifty 50. Bullish ahead by more than 2 points · Bearish behind by more than 2 points · Neutral within ±2 points.
50	Technical summary	26 bullish · 1 bearish · 21 neutral · 1 caution	Bullish	Across the 49 readings the technical picture leaned positive. Levels that mattered: support 2,225.03, resistance 2,413.85. This is a description of the chart on 10 Jul 2026, not a forecast. How to read the score: the strongest possible reading is 49 bullish · 0 bearish, and the weakest is 0 bullish · 49 bearish. Most companies land in between. The chart is called positive when bullish tags beat bearish ones by 5 or more, negative when bearish tags beat bullish ones by 5 or more, and mixed otherwise. Even a 49–0 score describes the past and is not a reason to buy, and a 0–49 score is not a reason to sell. Bullish bullish tags beat bearish ones by 5 or more (“positive”) · Bearish bearish tags beat bullish ones by 5 or more (“negative”) · Neutral (“mixed”) otherwise. Strongest possible: 49 bullish · 0 bearish.

Fundamental analysis — 50 points

Uses only results published by 10 Jul 2026: FY26 annual (Apr 2025–Mar 2026), the Jan–Mar 2026 quarter and the Mar 2026 shareholding. ₹ crore, consolidated unless stated. Valuation uses the 10 Jul 2026 close.

How to read the tags. Each of the 50 points gets one tag. Bullish the reading was favourable. Bearish the reading was unfavourable. Neutral the reading was in a normal range, or gave no clear message. Caution a warning sign or an unusual reading that deserves a closer look. Point 50 counts the other 49 tags. The numbers are called positive when bullish tags beat bearish ones by 4 or more and are at least 1.5 times as many, negative the other way round, and mixed otherwise. Under each point you will see what reading earns which tag. Tags describe the data on the snapshot date. They are not signals to buy or sell. Full guide to all 100 points →

A. Valuation

#	Point	Reading	Tag	Commentary
1	P/E (trailing 12 months)	47.4×	Neutral	At ₹2,282.90 the market valued the company at about ₹64,486 crore, or 47.4× the ₹1,361 crore profit of the four quarters to Mar 2026. That is a premium multiple — the market expected growth. How to read: Information only. Below 15 is a low multiple, 15–30 moderate, above 30 a premium (the market expects growth). Compare with peers and the company’s own history.
2	Price / Book	6.13×	Neutral	Market cap was 6.13× the Mar 2026 book value (equity + reserves) of ₹10,512 crore. How to read: Information only. Main yardstick for banks; asset-light businesses usually trade at high P/B.
3	Price / Sales	3.80×	Neutral	The company was valued at 3.80× its trailing-12-month sales of ₹16,983 crore. How to read: Information only.
4	EV / EBITDA (approx.)	14.2×	Neutral	Enterprise value (market cap + ₹594 cr borrowings; cash not netted) was 14.2× trailing operating profit of ₹4,574 crore. How to read: Information only. Lower means cheaper relative to operating profit.
5	Earnings yield	2.1%	Neutral	The inverse of P/E: each ₹100 invested bought about ₹2.1 of annual earnings. Investors often compare this with the ~6–7% yield on 10-year government bonds. How to read: Information only. Often compared with the ~6–7% yield on 10-year government bonds.
6	PEG (P/E ÷ 3-yr profit CAGR)	0.89	Caution	P/E of 47.4 divided by 3-year profit growth of 53.4% a year gives a PEG of 0.89. Below 1 is often read as growth being cheaply priced; above 2 as expensive. Note: the Sep 2025 quarter carried unusual other income of ₹-1,184 crore — a one-off that distorts year-on-year profit comparisons. Bullish below 1 (growth cheaply priced) · Bearish above 2 (growth expensively priced) · Neutral 1–2, or when profit did not grow (not meaningful).
7	Dividend yield (trailing 12M)	0.22%	Neutral	Dividends with ex-dates in the 12 months to the snapshot totalled ₹5 a share, a 0.22% yield on the ₹2,282.90 price. Bullish above 3% · Neutral at 3% or less. Never tagged Bearish.
8	Market capitalisation	₹64,486 cr	Neutral	At about ₹0.64 lakh crore the company was a mid-cap. How to read: Information only. Above ₹1 lakh crore large-cap, ₹30,000 crore–₹1 lakh crore mid-cap, below that small-cap (our rule of thumb).
9	Graham number vs price	₹635.16 vs ₹2,282.90	Neutral	Benjamin Graham's conservative fair-value yardstick √(22.5 × EPS × book value per share) came to ₹635.16; the price was 259% above it. Quality franchises usually trade above this number. Bullish price below the Graham number · Neutral when the price is above it (most quality companies are).

B. Growth

#	Point	Reading	Tag	Commentary
10	Revenue growth FY26 (YoY)	+27.5%	Bullish	Revenue for FY26 was ₹16,983 crore, +27.5% versus FY25. Bullish above 10% · Bearish below 0% (revenue fell) · Neutral 0–10%.
11	Q4 FY26 revenue growth (YoY)	+15.8%	Bullish	The Jan–Mar 2026 quarter brought ₹3,771 crore of revenue, +15.8% on the same quarter a year earlier. Bullish above 10% · Bearish below 0% · Neutral 0–10%.
12	Net profit growth FY26 (YoY)	+30.1%	Caution	FY26 net profit was ₹1,362 crore, +30.1% on FY25's ₹1,047 crore. Note: the Sep 2025 quarter carried unusual other income of ₹-1,184 crore — a one-off that distorts year-on-year profit comparisons. Bullish above 10% · Bearish below 0% · Neutral 0–10%. Caution if a one-off item distorted the figure.
13	Q4 FY26 profit growth (YoY)	+7425.0%	Caution	Quarterly profit was ₹301 crore versus ₹4 crore a year earlier (+7425.0%). Note: the Sep 2025 quarter carried unusual other income of ₹-1,184 crore — a one-off that distorts year-on-year profit comparisons. Bullish above 10% · Bearish below 0% · Neutral 0–10%.
14	Revenue CAGR (3 years)	13.6%	Bullish	Revenue compounded at 13.6% a year from FY23 to FY26. Bullish above 12% a year · Bearish below 5% a year · Neutral 5–12%. Caution if an acquisition inflated it.
15	Profit CAGR (3 years)	53.4%	Caution	Net profit compounded at 53.4% a year from FY23 to FY26. Note: the Sep 2025 quarter carried unusual other income of ₹-1,184 crore — a one-off that distorts year-on-year profit comparisons. Bullish above 12% a year · Bearish below 5% a year · Neutral 5–12%.
16	Revenue CAGR (5 years)	9.2%	Neutral	Over five years (FY21–FY26) revenue compounded at 9.2% a year. Bullish above 12% a year · Bearish below 5% a year · Neutral 5–12%.
17	EPS growth FY26 (reported)	+30.0%	Caution	Reported EPS went from ₹37.11 to ₹48.26 (+30.0%). Differences from profit growth come from changes in share count (bonus, buyback, new issues). Note: the Sep 2025 quarter carried unusual other income of ₹-1,184 crore — a one-off that distorts year-on-year profit comparisons. Bullish above 10% · Bearish below 0% · Neutral 0–10%.

C. Profitability

#	Point	Reading	Tag	Commentary
18	Operating margin FY26	27%	Neutral	Operating profit (EBITDA) was 27% of sales in FY26 versus 18% in FY25. How to read: Information only — normal margins differ a lot by industry.
19	Operating margin trend (4 quarters)	18% → 39% → 22% → 20%	Bullish	Quarterly margins moved from 18% to 20% over the last four quarters — expanding. Bullish up more than 1 percentage point · Bearish down more than 1 percentage point · Neutral when broadly stable.
20	Net profit margin FY26	8.0%	Neutral	₹8.0 of every ₹100 of revenue ended up as net profit in FY26. How to read: Information only.
21	Return on equity FY26	14.1%	Neutral	FY26 profit was 14.1% of average shareholders' equity. Above ~15% is generally considered good; below 10% weak. Bullish above 18% · Bearish below 10% · Neutral 10–18%. Around 15% or more is generally considered good.
22	ROCE FY26	40%	Bullish	Return on capital employed (debt + equity) was 40% in FY26. Bullish above 20% · Bearish below 10% · Neutral 10–20%.
23	Return on assets FY26	6.84%	Neutral	Net profit was 6.84% of total assets. Bullish banks only: 1.5% or more · Bearish banks only: below 1% · Information only for non-banks.
24	Effective tax rate FY26	31%	Neutral	The company paid about 31% of pre-tax profit as tax; India's base corporate rate is ~25%. How to read: Information only. India’s base corporate rate is about 25%.
25	Other income share of pre-tax profit	-91%	Neutral	Non-operating 'other income' of ₹-1,805 crore made up -91% of pre-tax profit. How to read: Caution above 25% (headline profit leans on non-core income). Neutral otherwise.

D. Balance sheet

#	Point	Reading	Tag	Commentary
26	Debt / equity	0.06	Bullish	Borrowings of ₹594 crore were 0.06× equity — very low leverage. Bullish below 0.3 (very low leverage) · Bearish above 1 (high leverage) · Neutral 0.3–1.
27	Debt / EBITDA	0.13×	Bullish	Debt equalled 0.13 years of FY26 operating profit. Bullish below 1× · Bearish above 3× · Neutral 1–3×.
28	Interest coverage	10.5×	Bullish	Earnings before interest and tax covered interest cost 10.5 times. Bullish above 8× · Bearish below 3× · Neutral 3–8×, or not meaningful when interest is negligible.
29	Book value growth	+18.8%	Bullish	Shareholders' equity grew +18.8% from ₹8,849 crore to ₹10,512 crore in FY26. Bullish above 10% (banks: above 12%) · Bearish below 0% (non-banks only) · Neutral otherwise.
30	Capital work in progress	₹909 cr (15% of fixed assets)	Neutral	Projects under construction (CWIP) were 15% of fixed assets — a modest pipeline. How to read: Information only. Above 20% means a big expansion pipeline that is not yet earning.
31	Working capital days	81 days	Neutral	Working capital tied up equalled 81 days of sales (FY25: 44). Negative means suppliers/customers fund operations. How to read: Information only. Lower is generally more efficient; negative means suppliers or customers fund the business.
32	Cash conversion cycle	83 days	Neutral	It took 83 days to turn inventory and receivables into cash, net of supplier credit. How to read: Information only. Shorter is generally better.
33	Debtor days	107 (FY25 92)	Neutral	Customers took 107 days on average to pay, versus 92 a year earlier. How to read: Caution when debtor days rose more than 20% in a year (collections stretching). Neutral otherwise.

E. Cash flow

#	Point	Reading	Tag	Commentary
34	Operating cash flow FY26	₹3,445 cr	Bullish	The business generated ₹3,445 crore of operating cash in FY26 versus ₹-828 crore in FY25. Bullish positive and higher than the year before · Bearish negative · Neutral when positive but lower. Information only for banks.
35	Free cash flow FY26	n/a	Neutral	Free cash flow line not available on source page. Bullish positive · Bearish negative · Neutral when not available.
36	Cash conversion (CFO ÷ net profit)	2.53×	Bullish	Operating cash flow was 2.53× reported profit — profits were well backed by cash. Bullish above 1× (profits well backed by cash) · Caution below 0.7×. Neutral 0.7–1×.
37	Free-cash-flow yield	n/a	Neutral	Not available. Bullish above 4% · Neutral at 4% or less.
38	Free cash flow — 3-year total	n/a	Neutral	Not available. Bullish positive total · Bearish negative total · Neutral when not available.
39	Capex FY26 (CFO – FCF)	n/a	Neutral	Not available. How to read: Information only.

F. Dividends & shareholder returns

#	Point	Reading	Tag	Commentary
40	Dividend payout ratio FY26	10%	Neutral	The company paid out about 10% of FY26 profit as dividends. How to read: Information only. High payout suits mature businesses; growing firms often keep more.
41	Dividend consistency (3 years)	-5% / 7% / 10%	Neutral	Payout ratios for FY24 / FY25 / FY26 — dividends were irregular. Bullish paid every year · Neutral when irregular. Never tagged Bearish.
42	Share capital change (FY25→FY26)	+0.0%	Neutral	Paid-up equity capital changed +0.0% (₹28 cr → ₹28 cr). Essentially unchanged — no dilution. Bullish fell 1% or more (a buyback) · Caution when it rose 1% or more (new shares issued). Neutral when unchanged, or for a bonus/split.

G. Ownership

#	Point	Reading	Tag	Commentary
43	Promoter holding	46.65% (+0.00 pts YoY)	Neutral	Promoters owned 46.65% at Mar 2026 versus 46.65% a year earlier. Bearish fell more than 1 percentage point in a year · Neutral otherwise. Never tagged Bullish.
44	Foreign institutional holding	20.35% (-2.80 pts YoY)	Bearish	FIIs held 20.35% at Mar 2026, down from 23.15% a year before. Bullish up more than 1 percentage point · Bearish down more than 1 percentage point · Neutral within ±1 point.
45	Domestic institutional holding	19.28% (+4.68 pts YoY)	Bullish	Mutual funds, insurers and other DIIs held 19.28%, up from 14.60%. Bullish up more than 1 percentage point · Bearish down more than 1 percentage point · Neutral within ±1 point.
46	Number of shareholders	2.0 lakh (+1.8% YoY)	Neutral	The shareholder count moved from 1.9 lakh to 2.0 lakh in a year — a rough gauge of retail interest. How to read: Information only — a rough gauge of retail interest.
47	Promoter pledge	none reported	Neutral	Our source showed no pledged promoter shares. How to read: Information only. Any sizeable pledge is a risk to note.

H. Quality & summary

#	Point	Reading	Tag	Commentary
48	Financial health checklist (Piotroski-style, 8 tests)	8/8	Bullish	Passed: positive profit, positive operating cash flow, CFO > net profit, leverage fell, operating margin improved, ROA improved, asset turnover improved, no meaningful dilution (<3%). Bullish all tests passed, or all but one · Bearish half the tests or fewer passed · Neutral in between.
49	Automated screen flags	3 strength(s) · 4 weakness(es)	Neutral	Strengths: Company has reduced debt; Company is almost debt free; Company has delivered good profit growth of 19.4% CAGR over last 5 years. Weaknesses: The company has delivered a poor sales growth of 9.19% over past five years; Company has a low return on equity of -3.28% over last 3 years; Debtor days have increased from 85.2 to 107 days; Working capital days have increased from 41.2 days to 80.5 days. (Flags generated by the data source’s rule screen.) How to read: Information only.
50	Fundamental summary	13 bullish · 1 bearish · 30 neutral · 5 caution	Bullish	On the numbers published by 10 Jul 2026 the fundamental picture leaned positive. Valuation: P/E 47.4×, P/B 6.13×. This describes the data, not a recommendation. How to read the score: the strongest possible reading is 49 bullish · 0 bearish, and the weakest is 0 bullish · 49 bearish. Most companies land in between. The numbers are called positive when bullish tags beat bearish ones by 4 or more and are at least 1.5 times as many, negative the other way round, and mixed otherwise. Even a 49–0 score describes the past and is not a reason to buy, and a 0–49 score is not a reason to sell. Bullish bullish tags beat bearish ones by 4 or more and are at least 1.5× as many (“positive”) · Bearish the same the other way round (“negative”) · Neutral (“mixed”) otherwise. Strongest possible: 49 bullish · 0 bearish.

News in the three months before the snapshot

Company news from 10 Apr 2026 – 10 Jul 2026 that an investor could have known on the snapshot date.

18 May 2026 Glenmark Pharmaceuticals Inc., USA launches Vancomycin Hydrochloride for Injection USP, 500 mg/vial and 1 g/vial — Glenmark's US subsidiary announced the launch of generic vancomycin hydrochloride for injection in two strengths. source
29 May 2026 Glenmark Pharmaceuticals announces Q4 & FY26 financial results — Q4 FY26 consolidated revenue from operations was Rs 3,770.6 crore, up 15.8% YoY; EBITDA Rs 762.6 crore (20.2% margin); PAT Rs 301.3 crore. FY26 PAT was Rs 1,362 crore. source
05 Jun 2026 Glenmark launches generic Lacosamide Injection USP in the US — The US subsidiary launched Lacosamide Injection 200 mg/20 mL, therapeutically equivalent to Vimpat Injection; IQVIA put the market at about $15.2 million for 12 months to April 2026. source
11 Jun 2026 Glenmark launches Winlevi (clascoterone) 10 mg/g cream in key European markets — Glenmark announced the launch of Winlevi cream for acne vulgaris in key European markets. source
02 Jul 2026 Glenmark advances multi-country Phase 3 trial of Trastuzumab rezetecan in platinum-resistant ovarian cancer — The company announced progress of a multi-country Phase 3 clinical trial of Trastuzumab rezetecan in platinum-resistant ovarian cancer. source
06 Jul 2026 Glenmark launches Olanzapine for Injection 10 mg/vial in the US — The US subsidiary launched a generic equivalent of Zyprexa IntraMuscular; IQVIA put the market at about $25.4 million for 12 months to May 2026. source

What happened next (10 Jul 2026 → 14 Oct 2026)

Price went from ₹2,282.90 to ₹2,246.00 by 14 Oct 2026 (-1.6%) while the Nifty 50 moved -6.5% — outperforming by 4.9 points.
Highest ₹2,537.60 on 28 Aug 2026; lowest ₹2,162.00 on 03 Aug 2026.
S1 2,225.03: broken on a closing basis on 22 Jul 2026.
S2 2,123.07: held on a closing basis.
R1 2,413.85: cleared on a closing basis on 26 Aug 2026.
R2 2,474.00: cleared on a closing basis on 28 Aug 2026.
200-day SMA: price was above it at the snapshot and crossed below on 08 Oct 2026.
Apr–Jun 2026 results (reported 31 Jul 2026): revenue ₹4,018 crore (+23.1% YoY), net profit ₹483 crore (+927.7% YoY), operating margin 20% vs 18% a year earlier (Screener consolidated figures).

Later news

28 Jul 2026 Glenmark launches generic Sugammadex Injection in the US — The US subsidiary launched Sugammadex Injection 200 mg/2 mL and 500 mg/5 mL, equivalent to Merck's BRIDION, after patent expiry; US market cited at about $1.6 billion for 12 months to May 2026. source
31 Jul 2026 Glenmark announces Q1 FY27 results; sets dividend record date — Q1 FY27 consolidated revenue Rs 4,018.5 crore (+23.1% YoY), EBITDA Rs 804.8 crore (20.0% margin), PAT Rs 482.8 crore. Record date for FY26 final dividend set as 31 Aug 2026. source
20 Aug 2026 Glenmark receives US FDA approval for Fluticasone Propionate Nasal Spray 50 mcg — US FDA approved the generic equivalent of Flonase Nasal Spray; IQVIA put US sales at about $295.2 million for 12 months to June 2026. source
11 Sep 2026 Glenmark launches RYALTRIS in Brazil — Glenmark announced the launch of its RYALTRIS nasal spray in Brazil. source
23 Sep 2026 Glenmark receives Establishment Inspection Report from US FDA for its Goa facility — The company announced receipt of an EIR from the US FDA for its Goa manufacturing facility. source

Educational summary. On 10 Jul 2026 the technical picture leaned positive and the fundamental picture leaned positive. Over the next three months the stock moved -1.6% against -6.5% for the Nifty 50. Here the chart's message did not line up neatly with what followed — a reminder that indicators describe the past, not the future. One case proves nothing on its own; the value is in seeing many cases over time. This page does not say whether to buy, sell or hold Glenmark Pharmaceuticals today.

Method designed by Pawan Kumar Sharma, CPA · ACCA · CIA. Numbers are computed by our engine from the sources listed below.

Sources: daily prices — Yahoo Finance history pages; financials and shareholding — Screener.in (fetched 15 Oct 2026); index — Nifty 50 via Yahoo Finance; news — linked articles. Calculations by Manage Our Finance. Report a correction

More case studies today

₹4,677.10close 10 Jul

Power transmission equipmentNSE: GVT&DData as of 10 Jul 2026

GE Vernova T&D India — 100-point case study

Technical

Fundamental

What happened next (3 months): -10.4% vs Nifty 50 -6.5%

Technical: was mixedFundamental: positiveP/E 97.4×P/B 44.64×RSI 461Y +96.4%

₹112.51close 10 Jul

Airport operatorNSE: GMRAIRPORTData as of 10 Jul 2026

GMR Airports — 100-point case study

Technical

Fundamental

What happened next (3 months): -19.8% vs Nifty 50 -6.5%

Technical: positiveFundamental: positiveP/E 251.7×P/B -43.26×RSI 611Y +21.9%

₹365.00close 10 Jul

Reinsurance (PSU)NSE: GICREData as of 10 Jul 2026

General Insurance Corporation of India — 100-point case study

Technical

Fundamental

What happened next (3 months): -12.2% vs Nifty 50 -6.5%

Technical: negativeFundamental: positiveP/E 6.6×P/B 0.91×RSI 471Y -3.1%